cjc 1295 ipamorelin clinical trial growth hormone secretagogue safety Comment “curious” for the full newsletter. 👇 The universe CJC-1295 (no DAC) + Ipamorelin

RAS inhibition in pancreatic cancer A long-standing moon-shot in pancreatic cancer has been a RAS inhibitor, to target the mutations that drive ~90% of cases

Also known as Alopecia, Baldness, Hair loss, or Androgenetic alopecia

It protects cells from oxidative stress by neutralizing free radicals and supporting detoxification pathways, particularly in the liver, immune cells, and central nervous system

Uncoupled Nitric Oxide Synthase : There are three isoforms of NOS: nNOS and eNOS are constitutively expressed, whereas the third one, inducible NOS (iNOS), is expressed in response to cytokines [78]

doi: 10.1093/gerona/glz101